Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Erika Lahm"'
Autor:
Andrea, Uhlyarik, Violetta, Piurkó, Zsuzsanna, Pápai, Erzsébet, Rásó, Erika, Lahm, Edina, Kiss, Márta, Sikter, József, Vachaja, Laura, Vízkeleti, István, Kenessey, József, Tímár
Publikováno v:
Magyar onkologia. 65(2)
Negative predictive markers of the anti-EGFR antibody therapies are RAS or BRAF mutations, while left sidedness can be considered as a positive predictor. Here we analyzed 97 wild type RAS metastatic colorectal cancers looking for the prognostic and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4855078d760ed6e7545b4950ccdc746f
https://pubmed.ncbi.nlm.nih.gov/34081760
https://pubmed.ncbi.nlm.nih.gov/34081760
Autor:
Zsolt Rozgonyi, Ibolya Soltész, József Kas, Gábor Grmela, Erika Lahm, Csaba Fehér, János Fillinger, Judit Varga, Attila Vágvölgyi, Zsuzsanna Papai, Pál Vadász, Attila Csekeő
Publikováno v:
Orvosi Hetilap. 159:149-153
Abstract: Infrequent solitary fibrous tumours of the pleura are associated with hypoglycaemia only in a few percent of the cases; this condition is called Doege–Potter syndrome, named after its first descriptors. Our 63 years old male patient has p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9862ec11ac673901f60b18a60270f2b
https://doi.org/10.1556/650.2018.30925
https://doi.org/10.1556/650.2018.30925
Autor:
Ross S. Berkowitz, Zsuzsanna Pápai, János Demeter, György Végh, Erika Lahm, János Szepesi, Iván Szigetvári, Vilmos Fülöp
Publikováno v:
European Journal of Gynaecological Oncology. 42:1159
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::82798b6b902e34e974bd5337a67775e7
https://doi.org/10.31083/j.ejgo4206169
https://doi.org/10.31083/j.ejgo4206169
Autor:
Andrea Uhlyarik, Violetta Piurkó, Erika Lahm, Marta Sikter, József Tímár, Erzsébet Rásó, István Kenessey, Edina Kiss, József Vachaja, Zsuzsanna Papai
Publikováno v:
Cancers
Volume 12
Issue 3
Cancers, Vol 12, Iss 3, p 614 (2020)
Volume 12
Issue 3
Cancers, Vol 12, Iss 3, p 614 (2020)
The selection of colorectal cancer patients for anti-epidermal growth factor receptor (EGFR) antibody therapy is based on the determination of their RAS mutation status&mdash
a strongly negative predictive factor&mdash
since the protein tar
a strongly negative predictive factor&mdash
since the protein tar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0d190426d31e31d1a3ad145b662bbab
https://doi.org/10.3390/cancers12030614
https://doi.org/10.3390/cancers12030614
Autor:
Violetta Piurkó, József Tímár, Laura Vízkeleti, Edina Kiss, Zs Pápai, István Kenessey, Marta Sikter, Erika Lahm, Andrea Uhlyarik, József Vachaja, Erzsébet Rásó
Publikováno v:
Pathology oncology research : POR. 26(3)
Right- and left-sided colorectal cancers (RSCRC and LSCRC, respectively) are different developmentally, genetically and prognostically. Clinical data also indicate that they respond differently to anti-EGFR therapies. The role of EGFR protein express
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::641581d06371a59cc4776b4d62bdf9b0
https://pubmed.ncbi.nlm.nih.gov/30612313
https://pubmed.ncbi.nlm.nih.gov/30612313
Autor:
József, Kas, Attila, Csekeő, Csaba, Fehér, Attila, Vágvölgyi, Gábor, Grmela, Judit, Varga, Zsolt, Rozgonyi, Ibolya, Soltész, János, Fillinger, Zsuzsanna, Pápai, Erika, Lahm, Pál, Vadász
Publikováno v:
Orvosi hetilap. 159(4)
Infrequent solitary fibrous tumours of the pleura are associated with hypoglycaemia only in a few percent of the cases; this condition is called Doege-Potter syndrome, named after its first descriptors. Our 63 years old male patient has previously un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::80322b8afab2b000d81d84a9a851fb7b
https://pubmed.ncbi.nlm.nih.gov/29353500
https://pubmed.ncbi.nlm.nih.gov/29353500
Autor:
ANDREA, UHLYARIK, VIOLETTA, PIURKÓ, ZSUZSANNA, PÁPAI, ERZSÉBET, RÁSÓ, ERIKA, LAHM, EDINA, KISS, MÁRTA, SIKTER, JÓZSEF, VACHAJA, LAURA, VÍZKELETI, ISTVÁN, KENESSEY, JÓZSEF, TÍMÁR
Publikováno v:
Magyar Onkologia; 2021, Vol. 65 Issue 2, p121-127, 7p
Autor:
Anikó, Maráz, Katalin, Boér, Zsófia, Dankovics, Magdolna, Dank, Erika, Lahm, Ágota, Petrányi, János, Révész, Ágnes, Ruzsa, Miklós, Szûcs, Anikó, Valikovics, Mária, Vas, Zsófia, Küronya
Publikováno v:
Magyar onkologia. 61(4)
Our aim was to assess the efficacy and adverse effects of cabazitaxel (CBZ), a chemotherapeutic agent that can be administered to patients with metastatic castrate resistant prostate cancer (mCRPC) after docetaxel (DOC) therapy. We retrospectively an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::aee4cc03640d088a346a3317849ab048
https://pubmed.ncbi.nlm.nih.gov/29257155
https://pubmed.ncbi.nlm.nih.gov/29257155
Publikováno v:
Orvosi Hetilap. 155:194-198
Although the incidence of neuroendocrine tumours is low, their prevalence is high due to the usually slow course of the disease. Between July 1, 2008 and July 1, 2013 the authors evaluated 56 patients with well-differentiated or moderately differenti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c49211cbd131a4b3381d201bdd924ea
https://doi.org/10.1556/oh.2014.29818
https://doi.org/10.1556/oh.2014.29818
Autor:
József Tímár, Edina Kiss, István Kenessey, Andrea Uhlyarik, Erzsébet Rásó, Violetta Piurkó, József Vachaja, Zsuzsa Papai, Erika Lahm, Marta Sikter
Publikováno v:
Journal of Clinical Oncology. 36:e15548-e15548
e15548Background: Anti-EGFR monoclonal antibody therapy is a standard treatment of advanced colorectal cancer. Unlike in case of other target therapies the target of anti-EGFR monoclonal antibodies...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3122c696d81f7d863785dce9ff979236
https://doi.org/10.1200/jco.2018.36.15_suppl.e15548
https://doi.org/10.1200/jco.2018.36.15_suppl.e15548